Igor Kohl

The management of acute otitis media

Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation

Potential Contribution by Nontypable Haemophilus influenzae in Protracted and Recurrent Acute Otitis Media

Epidemiology of otitis media in children from developing countries: A systematic review

Vaccines to prevent pneumonia and improve child survival

Immune modulation by bacterial outer membrane vesicles

Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?

The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease

The Diagnosis and Management of Acute Otitis Media

Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline

How to compare the efficacy of conjugate vaccines to prevent acute otitis media?

Prevention of otitis media: Now a reality?

Evolving concepts in biofilm infections

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012

Serotype Coverage of Invasive and Mucosal Pneumococcal Disease in Israeli Children Younger Than 3 Years by Various Pneumococcal Conjugate Vaccines

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Otitis media and its consequences: beyond the earache

Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

Initial findings of shortwave infrared otoscopy in a pediatric population

Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children

Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

New vaccines offering a larger spectrum of protection against acute otitis media: Will parents be willing to have their children immunized?

Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children

A review of the burden of disease due to otitis media in the Asia-Pacific

Vaccines in the era of genomics: The pneumococcal challenge

Protein carriers of conjugate vaccines: Characteristics, development and clinical trials

Prospects for Prevention of Otitis Media

Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates

Otitis media

Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age

10-valent pneumococcal nontypeableHaemophilus influenzaePD conjugate vaccine: Synflorix™

Pneumococcal conjugate vaccines for preventing otitis media

Bacterial Biofilm and its Role in the Pathogenesis of Disease

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Efficacy of Pneumococcal Vaccination in Children Younger Than 24 Months: A Meta-Analysis

New Vaccines Against Otitis Media: Projected Benefits and Cost-effectiveness

Clinical Practice Guideline (Update): Adult Sinusitis

Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold

Multiple Consecutive Lavage Samplings Reveal Greater Burden of Disease and Provide Direct Access to the Nontypeable Haemophilus influenzae Biofilm in Experimental Otitis Media

Clinical Practice Guideline: Otitis Media with Effusion (Update)

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non‐typable Haemophilus influenzae: a randomised double‐blind efficacy study